Онлайн КрасотаКаталог

Брошюра «Клинические исследования пептидных биорегуляторов» Электронная версия на английском языке — страница 90

Книги и пособия · 125 страниц · 0.7 МБ · Полное издание

Читать текстСкачать PDF
Chitomur® The condition of patients with BPH after treatment with CHITOMUR® was characterized by an im- provement in subjective and objective indicators of urodynamics. It should be noted that uroflograms recorded after treatment in patients with BPH stages I and II showed the restoration of the basic parameters of urination to normal values. At stage III of the dis- ease, this was prevented by a decrease in the elasticity of the bladder neck due to sclerotic changes in the tissue of the prostate gland. Still, a noticeable increase in the urine stream was observed in such patients. The patients’ assessment of their bladder condition significantly improved. In women with climacteric syndrome, accompanied by an overactive bladder, the use of CHITOMUR® achieved a 38% reduction in urgency and incontinence episodes by 43%. The degree of discomfort due to imperative symptoms decreased 1.8 times, the degree of anxiety decreased by 57%, and satisfaction with treatment reached 78%. Thus, according to the patients’ self-esteem, the decrease in anxiety caused by the symptoms of urinary dysfunction is 1.8 times, comes ahead of the very positive dynamics of these symptoms, which indicates a predominant improvement in the quality of life of women as a result of treatment. A month after the course of treatment using CHITOMUR®, all patients retained the improvement in symptoms. After discontinuation of the drug, the bladder capacity increased by 10-20% with various urges to urinate, which is explained by a decrease in detrusor ischemia, which plays a significant role in the pathogenesis of OAB. Thus, the results of this study indicate the therapeutic efficacy of CHITOMUR® and the practicality of its use in the complex treatment of dysuric disorders of various origins, including in diseases of the prostate gland in men and women with symptoms of an overactive bladder. CHITOMUR® does not cause side effects, complications, or drug dependence and can be used for therapeutic and prophylactic purposes, combined with any means of symptomatic therapy used in urological practice (antibacterial agents, antispasmodics, vascular and hormonal drugs, vitamins, etc.) CONCLUSION Biologically active food supplement CHITOMUR® has a regulating effect on the functional activity of the cells of the wall and detrusor cells of the bladder and helps normalize urination function. CHITOMUR®is well tolerated when taken orally, has no side effects, and can be used as a therapeutic and prophylactic biologically active food supplement. CHITOMUR®is recommended for patients with impaired urination function of various origins - oral- ly during meals, 1-2 capsules or tablets 2 times a day for 30 days. It is recommended to repeat the course of treatment in 3-6 months. REFERENCES 1. Mashkovsky M.D., Medicines: Pharmacotherapy for doctors, manual: 2 parts. – Vilnius: ZAO “Gam- ta”, 1993. 2. Guide to Andrology / Ed. O. L. Tiktinsky. - L.: Medicine, 1990. -- 416 p. 3. Sexopathology: A Handbook / Ed. G.S. Vasilchenko. - M.: Medicine, 1990. -- 576 p.

Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.

Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.